Atlas Trials

Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer

Clinical trial NCT06128837 · RECRUITING

Trial details

NCT number
NCT06128837
Sponsor
Luye Pharma Group Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsed Small Cell Lung Cancer
Start date
2024-03-03
Primary completion
2028-06-01
Enrollment
686

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.